30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Karuna Therapeutics Inc. (KRTX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Farallon Capital Thomas Steyer | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | ||
| 3. | Avidity Partners Management David Witzke And Michael Gregory | 0 | $0 | 0% | |
| 4. | Glazer Capital Paul Glazer | 0 | $0 | 0% | |
| 5. | Pentwater Capital Management Matthew Halbower | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $123.39 | 24,161 | Director | 2,072,441 | 2022-06-30 | Filing | |
| $122.27 | 48,062 | Director | 2,048,280 | 2022-06-30 | Filing | |
| $125.00 | 9,129 | Director | 2,000,218 | 2022-06-29 | Filing | |
| $124.73 | 6,832 | Director | 1,991,089 | 2022-06-29 | Filing | |
| $122.95 | 4,039 | Director | 1,984,257 | 2022-06-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $318.96 | 100 | 42,604 | 2024-03-08 | Filing | ||
| $318.33 | 4,900 | 42,704 | 2024-03-08 | Filing | ||
| $316.56 | 818 | 41,150 | 2024-02-08 | Filing | ||
| $316.05 | 4,182 | 41,968 | 2024-02-08 | Filing | ||
| $316.81 | 15,000 | 38,650 | 2024-01-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,227,102 | $1,337,920,054 | 0.29% | |
| 2. | 3,224,786 | $1,020,677,017 | 0.02% | |
| 3. | 2,865,994 | $907,115,761 | 0.06% | |
| 4. | 2,015,374 | $637,886,026 | 0.01% | |
| 5. | 1,381,149 | $437,147,470 | 24.46% |
News See All
Bronte Amalthea Fund Incurred Loss in Karuna Therapeutics (KRTX) Short Position
Bronte Capital, an investment management company, released its “Amalthea Fund” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
Karuna Therapeutics (KRTX) Rose on Acquisition Announcement
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
Karuna Therapeutics, Inc. (NASDAQ:KRTX) Q3 2023 Earnings Call Transcript
Operator: Welcome to the Karuna Therapeutics Third Quarter 2023 Financial Results Conference Call. All participants are in a listen-only mode. Please note, this call is being recorded.
What Makes Karuna Therapeutics (KRTX) a Prospective Investment?
ClearBridge Investments, an investment management company, released its “ClearBridge SMID Cap Growth Strategy” second quarter 2023 investor letter. A copy of the same can be downloaded here.
5 Best High Risk High Reward Stocks To Buy Now
In this piece, we will take a look at the five best high risk high reward stocks to buy now.
10 Oversold Healthcare Stocks to Buy
In this article, we will take a look at the 10 healthcare stocks to buy.
Karuna Therapeutics, Inc. (NASDAQ:KRTX) Q2 2023 Earnings Call Transcript
Operator: Welcome to the Karuna Therapeutics Second Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note that this call is being recorded.
Karuna Therapeutics, Inc. (NASDAQ:KRTX) Q1 2023 Earnings Call Transcript
Operator: Welcome to the Karuna Therapeutics First Quarter 2023 Financial Results Conference Call. All participants are in a listen-only mode. Please note this call is being recorded.
11 Best Mid-Cap Healthcare Stocks To Buy Now
The healthcare industry outlook is currently uncertain due to a combination of factors such as economic troubles, a shortage of healthcare workers, and the ongoing COVID-19 pandemic.
Billionaire Hedge Funds
